tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Cash flow

Compare
629 Followers

Sonnet BioTherapeutics Holdings Cash Flow

SONN's free cash flow for Q3 2025 was $-1.76M. For the 2025 fiscal year, SONN's free cash flow was decreased by $13.18M and operating cash flow was $-1.76M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -8.61M$ -21.34M$ -27.69M$ -22.55M$ -15.61M
Investing Cash Flow
$ -12.00K$ -443.25K$ -896.48K$ -3.62K$ -76.18K
Financing Cash Flow
$ 6.49M$ 21.01M$ 4.01M$ 42.83M$ 23.01M
End Cash Position
$ 149.46K$ 2.27M$ 3.05M$ 27.62M$ 7.35M
Free Cash Flow
$ -8.61M$ -21.79M$ -28.58M$ -22.56M$ -15.69M
Currency in USD

Sonnet BioTherapeutics Holdings Cash Flow